These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

237 related articles for article (PubMed ID: 12365409)

  • 21. [Prevention and immunotherapy of staphylococcal infections with bacterial vaccines].
    Kuz'menko OM; Gruber IM; Priiatkin RG
    Zh Mikrobiol Epidemiol Immunobiol; 2010; (5):106-12. PubMed ID: 21061586
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Evaluation of immunological parameters in rabbits inoculated with Staphylococcus aureus in view of specific and non-specific stimulation.
    Giedrys-Galant S; Podkowińska I; Hałasa J; Bohatyrewicz R; Daszko J
    Arch Immunol Ther Exp (Warsz); 1978; 26(1-6):583-7. PubMed ID: 749812
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The prospects for developing a vaccine against Staphylococcus aureus.
    Lee JC
    Trends Microbiol; 1996 Apr; 4(4):162-6. PubMed ID: 8728611
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A new view on development of a Staphylococcus aureus vaccine: insights from mice and men.
    Spellberg B; Daum R
    Hum Vaccin; 2010 Oct; 6(10):857-9. PubMed ID: 20930569
    [No Abstract]   [Full Text] [Related]  

  • 25.
    Wójcik-Bojek U; Różalska B; Sadowska B
    Int J Mol Sci; 2022 Jan; 23(2):. PubMed ID: 35055134
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Staphylococcal vaccine development: review of past failures and plea for a future evaluation of vaccine efficacy not only on staphylococcal infections but also on mucosal carriage.
    Botelho-Nevers E; Verhoeven P; Paul S; Grattard F; Pozzetto B; Berthelot P; Lucht F
    Expert Rev Vaccines; 2013 Nov; 12(11):1249-59. PubMed ID: 24111513
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Development of StaphVAX, a polysaccharide conjugate vaccine against S. aureus infection: from the lab bench to phase III clinical trials.
    Fattom AI; Horwith G; Fuller S; Propst M; Naso R
    Vaccine; 2004 Feb; 22(7):880-7. PubMed ID: 15040941
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Immune responses to a Staphylococcus aureus GapC/B chimera and its potential use as a component of a vaccine for S. aureus mastitis.
    Perez-Casal J; Prysliak T; Kerro-Dego O; Potter AA
    Vet Immunol Immunopathol; 2006 Jan; 109(1-2):85-97. PubMed ID: 16165220
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Experimental trial in heifers vaccinated with Staphylococcus aureus avirulent mutant against bovine mastitis.
    Pellegrino M; Giraudo J; Raspanti C; Nagel R; Odierno L; Primo V; Bogni C
    Vet Microbiol; 2008 Feb; 127(1-2):186-90. PubMed ID: 17869031
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Biologic properties and vaccine potential of the staphylococcal poly-N-acetyl glucosamine surface polysaccharide.
    Maira-Litran T; Kropec A; Goldmann D; Pier GB
    Vaccine; 2004 Feb; 22(7):872-9. PubMed ID: 15040940
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Evasion of Immunological Memory by
    Teymournejad O; Montgomery CP
    Front Immunol; 2021; 12():633672. PubMed ID: 33692805
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Protection against Staphylococcus aureus and tetanus infections by a combined vaccine containing SasA and TeNT‑Hc in mice.
    Yang Y; Yu R; Yang X; Liu S; Fang T; Song X; Hou L; Yu C; Xu J; Fu L; Yi S; Chen W
    Mol Med Rep; 2017 Apr; 15(4):2369-2373. PubMed ID: 28259925
    [TBL] [Abstract][Full Text] [Related]  

  • 33. DNA-protein immunization against the GapB and GapC proteins of a mastitis isolate of Staphylococcus aureus.
    Kerro-Dego O; Prysliak T; Potter AA; Perez-Casal J
    Vet Immunol Immunopathol; 2006 Sep; 113(1-2):125-38. PubMed ID: 16777237
    [TBL] [Abstract][Full Text] [Related]  

  • 34. An experimental vaccine that targets staphylococcal virulence.
    Lee JC
    Trends Microbiol; 1998 Dec; 6(12):461-3. PubMed ID: 10036720
    [No Abstract]   [Full Text] [Related]  

  • 35. [Controversy in asthma. II. A new vaccine prepared with the Cowan I strain of Staphylococcus aureus].
    del Real Sánchez JH
    Rev Alerg Mex (1987); 1987; 34(4):99-105. PubMed ID: 3324814
    [No Abstract]   [Full Text] [Related]  

  • 36. Lack of protection of mice against Staphylococcus aureus despite a significant immune response to immunization with a DNA vaccine encoding collagen-binding protein.
    Therrien R; Lacasse P; Grondin G; Talbot BG
    Vaccine; 2007 Jun; 25(27):5053-61. PubMed ID: 17532546
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Inferring reasons for the failure of Staphylococcus aureus vaccines in clinical trials.
    Bagnoli F; Bertholet S; Grandi G
    Front Cell Infect Microbiol; 2012; 2():16. PubMed ID: 22919608
    [No Abstract]   [Full Text] [Related]  

  • 38. [Immunogenicity and antigenic properties of staphylococcal toxoid and vaccine in laboratory animals. II. Staphylococcal vaccine].
    Wysokińska T; Albrycht H
    Med Dosw Mikrobiol; 1973; 25(3):205-11. PubMed ID: 4760223
    [No Abstract]   [Full Text] [Related]  

  • 39. A MRSA-terious enemy among us: boosting MRSA vaccines.
    Kobayashi SD; DeLeo FR
    Nat Med; 2011 Feb; 17(2):168-9. PubMed ID: 21297611
    [No Abstract]   [Full Text] [Related]  

  • 40. Models matter: the search for an effective Staphylococcus aureus vaccine.
    Salgado-Pabón W; Schlievert PM
    Nat Rev Microbiol; 2014 Aug; 12(8):585-91. PubMed ID: 24998740
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.